A Cost–Benefit Approach
Chapter 36: Introduction to IV
36. Introduction to Part IV By now it should be fully clear why the setting of MDGs was not very helpful. It is true that seeking to halve the spread of HIV/AIDS by 2015 does at least try to ensure that that there is some accountability for all the monies that have been devoted to this disease. In this way the effectiveness of interventions would be an issue. There cannot be no improvement. But, why a 50 percent improvement should be feasible when no mention is made of how the improvement is to be achieved makes no sense. Moreover, we need to know why a 50 percent improvement is better than any other rate of improvement. CBA on the other hand, would enable us to answer all the relevant questions, not only about whether particular interventions are effective or not, but also about whether any or all of them are worthwhile. We add up all the worthwhile interventions so that we can find what the resulting level of improvement can be and then determine what the total necessary expenditures should be. Part III covered some of the necessary ingredients of CBA. Many of the technical details were omitted, especially a discussion of the statistical methods that need to be employed to analyze the data so that they can estimate the inputs, outputs, effects, benefits and costs. The aim was not to prepare the reader to carry out a CBA for him/herself. Rather the object was to show the many ways...
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.